Not a Member?

Gain industry knowledge, learn best practices, network with peers, and advance your career with the largest not-for-profit association in the pharmaceutical industry.

Join now and get Member Pricing on your purchase!

Learn More
 
ISPE Report: Increasing Domestic Resiliency Supply Ess APIs
ISPE Report: Increasing Domestic Resiliency Supply Ess APIs
ISPE Report: Increasing Domestic Resiliency in the Supply of Essential APIs
0.00
ISPE produced this report in response to a request from the US Department of Air Force Acquisition COVID-19 Task Force (DAF ACT) to advise regulatory, technical, and workforce elements favorable to creating a more robust and sustainable domestic pharmaceutical manufacturing base for Active Pharmaceutical Ingredients (APIs). The report lays out technical, regulatory and workforce changes that stakeholders in any country or region could consider to reduce the risks of API shortages to meet demands for essential medicines at any time, but particularly in pandemics and other emergencies.

Member Price: $ 0.00
Non Member Price: $ 0.00
Item #: RIRDAFACTDL